• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.

作者信息

Rustum Y M, Dave C, Mayhew E, Papahadjopoulos D

出版信息

Cancer Res. 1979 Apr;39(4):1390-5.

PMID:421223
Abstract
摘要

相似文献

1
Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.脂质体类型和给药途径在脂质体包裹的1-β-D-阿拉伯呋喃糖基胞嘧啶对小鼠L1210白血病抗肿瘤活性中的作用
Cancer Res. 1979 Apr;39(4):1390-5.
2
Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.隐形脂质体：一种用于1-β-D-阿拉伯呋喃糖基胞嘧啶的改进型缓释系统。
Cancer Res. 1992 May 1;52(9):2431-9.
3
Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine.脂质体包裹的1-β-D-阿拉伯呋喃糖基胞嘧啶对小鼠中枢神经系统白血病的治疗
Cancer Res. 1989 Sep 15;49(18):5097-102.
4
Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.包裹于脂质体中的一种水不溶性化合物对小鼠L1210白血病的抗肿瘤活性。
J Natl Cancer Inst. 1983 Jun;70(6):1081-6.
5
Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.胆固醇在增强脂质体包裹的阿糖胞苷抗肿瘤活性中的作用。
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1923-8.
6
Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.胆固醇含量对脂质体包裹的1-β-D-阿拉伯呋喃糖基胞嘧啶体内抗肿瘤活性和毒性的影响。
Cancer Res. 1980 Mar;40(3):630-3.
7
[Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].新型阿糖胞苷类似物4-氨基-1-β-D-阿拉伯呋喃糖基-2（1H）-嘧啶酮5'-（十八烷基磷酸钠）一水合物（YNK01）的抗肿瘤活性
Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 1):1437-45.
8
Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice.1-β-D-阿拉伯呋喃糖基胞嘧啶5'-金刚烷酸酯（NSC 117614）对L1210白血病小鼠的抗肿瘤作用。
Cancer Res. 1970 Apr;30(4):1047-54.
9
Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles.包裹于磷脂囊泡内的1-β-D-阿拉伯呋喃糖基胞嘧啶对肿瘤细胞体外和体内生长的抑制作用。
Cancer Res. 1976 Dec;36(12):4406-11.
10
Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.四氢尿苷对L1210白血病小鼠中1-β-D-阿拉伯呋喃糖基胞嘧啶（阿糖胞苷）口服活性的增强作用。
Cancer Res. 1970 Aug;30(8):2166-72.

引用本文的文献

1
Innovative approach to the detection of circulating tumor biomarkers: multi-dimensional application of liposome technology.循环肿瘤生物标志物检测的创新方法：脂质体技术的多维应用
Lipids Health Dis. 2025 Apr 28;24(1):160. doi: 10.1186/s12944-025-02578-7.
2
Clinical potential of elacytarabine in patients with acute myeloid leukemia.阿糖胞苷乙酯在急性髓系白血病患者中的临床潜力。
Ther Adv Hematol. 2014 Dec;5(6):211-20. doi: 10.1177/2040620714552615.
3
Clinical pharmacokinetics of cytarabine formulations.阿糖胞苷制剂的临床药代动力学。
Clin Pharmacokinet. 2002;41(10):705-18. doi: 10.2165/00003088-200241100-00002.
4
Liposomes as carriers of cancer chemotherapy. Current status and future prospects.脂质体作为癌症化疗的载体。现状与未来展望。
Drugs. 1993 Oct;46(4):618-38. doi: 10.2165/00003495-199346040-00004.
5
Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.脂质体包裹的阿糖胞苷三磷酸（AraCTP）在体外克服小鼠淋巴瘤中的阿糖胞苷（AraC）耐药性。
Br J Cancer. 1982 Apr;45(4):559-64. doi: 10.1038/bjc.1982.92.
6
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.柔红霉素与蛋白质之间的共价连接，这种连接在血清中稳定且可被溶酶体水解酶逆转，这是溶酶体靶向药物 - 载体缀合物所必需的：体外和体内研究。
Proc Natl Acad Sci U S A. 1982 Jan;79(2):626-9. doi: 10.1073/pnas.79.2.626.
7
Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.使用阴离子脂质体降低慢性阿霉素诱导的心脏毒性。
Proc Natl Acad Sci U S A. 1981 Mar;78(3):1873-7. doi: 10.1073/pnas.78.3.1873.
8
Liposomes as vehicles for cellular incorporation of biologically active macromolecules.脂质体作为生物活性大分子细胞内吞的载体。
In Vitro. 1980 Jan;16(1):49-54. doi: 10.1007/BF02618199.
9
Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.脂质体作为顺二氨二氯铂（II）的药物载体系统。II. 体内抗肿瘤活性、耐药性诱导、肾毒性及铂分布
Cancer Chemother Pharmacol. 1988;21(4):299-307. doi: 10.1007/BF00264195.
10
Liposomes in chemo- and immunotherapy of cancer.脂质体在癌症化学疗法和免疫疗法中的应用
Lipids. 1987 Nov;22(11):891-6. doi: 10.1007/BF02535550.